Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma

被引：0
|
作者：
Gayatri Behera
Suvradeep Mitra
Tushar S Mishra
Suvendu Purkait
机构：
[1] AIIMS,Department of Pathology and Lab Medicine
[2] AIIMS,Department of Trauma and Emergency
来源：
Journal of Gastrointestinal Cancer | 2021年 / 52卷
关键词：
Gallbladder; Carcinoma ; Dysplasia ; Epigenetic ; EZH2 ; H3K27me3; DNMT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1029 / 1034
页数：5
相关论文
共 50 条
  • [31] The Overexpression of Enhancer of Zeste Homolog 2 (EZH2) May Be Related to Malignant Behaviors in Intraductal Papillary Neoplasm of the Bile Duct
    Sasaki, M.
    Matsubara, T.
    Sato, Y.
    Yoneda, N.
    Nakanuma, Y.
    LABORATORY INVESTIGATION, 2012, 92 : 424A - 424A
  • [32] The Overexpression of Enhancer of Zeste Homolog 2 (EZH2) May Be Related to Malignant Behaviors in Intraductal Papillary Neoplasm of the Bile Duct
    Sasaki, M.
    Matsubara, T.
    Sato, Y.
    Yoneda, N.
    Nakanuma, Y.
    MODERN PATHOLOGY, 2012, 25 : 424A - 424A
  • [33] Enhancer of zeste homolog 2 (EZH2) inhibition in metastatic melanoma promotes tumor regression in vivo
    Sengupta, Deepanwita
    Avaritt, Nathan
    Shalin, Sara C.
    Tackett, Alan J.
    CANCER RESEARCH, 2016, 76
  • [34] The enhancer of zeste homolog 2 (EZH2) expression level correlates with clinical grading of bladder carcinomas
    Muller, M
    Krause, H
    Weikert, S
    Miller, K
    JOURNAL OF UROLOGY, 2004, 171 (04): : 194 - 194
  • [35] Enhancer of Zeste Homolog 2 (EZH2) in COVID-19-Positive Acute Myeloid Leukemia
    Hamed, Nahla
    Gallab, Omar
    Abdelhalim, Reham
    Rezk, Mohamed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S289 - S290
  • [36] Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis
    Cheng, Tianci
    Xu, Yinghui
    MEDICAL SCIENCE MONITOR, 2018, 24 : 7249 - 7255
  • [37] Overexpression of enhancer of zeste homolog 2 (EZH2), focal adhesion kinase (FAK), and pFAK in high grade endometrial carcinoma
    Semaan, A.
    Mert, I.
    Solomon, L.
    Morris, R.
    Munkarah, A.
    Sood, A.
    Ali-Fehmi, R.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S164 - S165
  • [38] Enhancer of Zeste Homologue 2 (EZH2) may relate to progression of intra and extrahepatic cholangiocarcinoma
    Nakagawa, Shigeki
    Okabe, Hlrohisa
    Beppu, Toru
    Kuroki, Hideyuki
    Mima, Kousuke
    Hayashi, Hiromitu
    Imai, Katsunori
    Nitta, Hidetoshi
    Nakahara, Osamu
    Ikuta, Yoshiaki
    Chikamoto, Akira
    Ishiko, Takatoshi
    Takamori, Hiroshi
    Baba, Hideo
    CANCER RESEARCH, 2012, 72
  • [39] Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes
    Sakhdari, Ali
    Class, Caleb
    Montalban-Bravo, Guillermo
    Sasaki, Koji
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Routbort, Mark J.
    Loghavi, Sanam
    Ok, Chi Young
    Quesada, Andres
    Khoury, Joseph D.
    Konoplev, Sergej N.
    Kantarjian, Hagop P.
    Garcia-Manero, Guillermo
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    MODERN PATHOLOGY, 2022, 35 (09) : 1212 - 1219
  • [40] Enhancer zeste homolog 2 (EZH2) targeting by small interfering RNA (siRNA); recent advances and prospect
    Hsu, Chou-Yi
    Mohammed, Abdulsalam Najm
    Hjazi, Ahmed
    Uthirapathy, Subasini
    Renuka, Jyothi S.
    Singh, Abhayveer
    Thyagarajan, Subhashree
    Ray, Subhashree
    Hulail, Hanen Mahmod
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
12345